To tackle the opioid crisis, the Trump administration should push for the Alternatives to PAIN Act in Congress, which would ...
Seniors are at higher risk for opioid problems for a simple reason – they are more likely to need outpatient surgeries.
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
MarketBeat on MSN2d
Vertex's Pain Drug: Big Pharma's Next Major Success?Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...
The DOJ filed a civil lawsuit against a Stockton nurse practitioner accused of running a nationwide scheme to sell illegal ...
He determined that the reason for the failure of major pharmaceutical companies to develop non-narcotic pain relievers at that time was that they focused only on the development of drugs acting on ...
It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex ...
A Rutgers study shows acetaminophen and ibuprofen outperform opioids for pain relief after wisdom tooth removal, leading to better outcomes and supporting ADA guidance to avoid opioids as first-line ...
Hosted on MSN4d
Interview: “Vivozon’s oral non-opioid painkiller in development, paving way for U.S. addiction solutions”Unafra, with the active ingredient opiranserin hydrochloride, is an injectable medication developed for managing ...
WHAM – Rochester on MSN4d
UR Medicine study aims to reduce opioid prescriptions after dental surgeriesA new landmark study involving the University of Rochester could change how dentists treat pain after wisdom tooth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback